Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 9 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025, Mar 2026, Apr 2026, May 2026, Jun 2026, Jul 2026, Aug 2026, Sep 2026 and Oct 2026.
- Largest single sale: $6.8M (97,926 shares) of Cytokinetics Inc on Sep 15, 2026. Filing
- Last sale before this period: Oct 1, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Cytokinetics Inc (CYTK) | President & CEO, Director | Apr 28, 2004 | Oct 13, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 12, 2026, Cytokinetics Inc: sold 7,500 shares for $472K, under a disclosed plan; 7,500 shares acquired by exercising options. 1 filing: 1
- Sep 28, 2026, Cytokinetics Inc: sold 7,500 shares for $491K, under a disclosed plan; 7,500 shares acquired by exercising options. 1 filing: 1
- Sep 15, 2026, Cytokinetics Inc: sold 97,926 shares for $6.8M, under a disclosed plan (some held indirectly). 1 filing: 1
- Sep 14, 2026, Cytokinetics Inc: sold 7,500 shares for $551K, under a disclosed plan; 7,500 shares acquired by exercising options; 1,350 shares given away; 195,852 shares moved between their own holdings (some held indirectly). 1 filing: 1
- Aug 31, 2026, Cytokinetics Inc: sold 7,500 shares for $527K, under a disclosed plan; 7,500 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.